[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100538637":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":13,"locations":7,"responsibleParty":19,"collaborators":7,"id":21,"slug":22,"hasResults":23,"nctId":24,"briefTitle":25,"officialTitle":26,"acronym":27,"eligibilityCriteria":28,"healthyVolunteers":23,"sex":29,"minAge":30,"maxAge":7,"enrollmentInfo":31,"targetDuration":7,"studyType":34,"phases":7,"briefSummary":35,"conditions":36,"keywords":7,"overallStatus":40,"whyStopped":7,"lastUpdateSubmitDate":41,"lastUpdatePostDateStruct":42,"startDateStruct":45,"completionDateStruct":47,"leadSponsor":49,"locationsCount":7},{"fullName":5,"class":6},"LUMA Vision Ltd.","INDUSTRY",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DEVICE","VERAFEYE System","VERAFEYE system guidance will be used on all patients undergoing AF ablation and\u002For LAAC procedures.",[14],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Elke Sommerijns","CONTACT","+32479767156","elke.sommerijns@lumavision.com",{"type":20,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100538637","registry-on-luma-visions-verafeye-system-enlight-100538637",false,"NCT06293430","Registry on Luma Vision's VERAFEYE System (ENLIgHT)","Registry on Luma Vision's VERAFEYE System in Catheter Ablation and Left Atrial Appendage Closure Procedures","ENLIgHT","Key Inclusion Criteria:\n\n* Subject is 18 years of age or of legal age to give informed consent specific to state and national law at the time of consent\n* Subjects is indicated for an atrial fibrillation ablation and\u002For a left atrial appendage closure procedure with the VERAFEYE System as navigation and imaging system, per physician discretion;\n* Subject is able to understand and willing to provide written informed consent\n* Subject is able and willing to complete all study assessments at an approved clinical investigational center\n\nKey Exclusion Criteria:\n\n* Subjects who have undergone a previous cardiac ablation for the treatment of PAF\u002FLAA Closure\n* Subject where placement of VERAFEYE Imaging Catheter is technically not feasible per physician discretion\n* Pregnant women or women who plan to become pregnant during the course of their participation in the study (women should either be of non- childbearing potential at the time of enrolment (as documented in the medical file) or have a negative pregnancy test within the previous 7 days prior to the procedure)\n* Unrecovered\u002Funresolved Adverse Events from any previous invasive procedure\n* Subjects who are currently enrolled in another study (except when the subject is participating in a mandatory governmental registry, or a purely observational registry with no associated treatments)","ALL","18 Years",{"count":32,"type":33},50,"ESTIMATED","OBSERVATIONAL","The objective of the study is to compile real-world data on the use of the VERAFEYE System in standard of care atrial fibrillation (AF) ablation procedures and left atrial appendage closure (LAAC) procedures.",[37,38,39],"Atrial Fibrillation","Left Atrial Appendage Closure","Atrial Arrhythmia","NOT_YET_RECRUITING","2026-06-09",{"date":43,"type":44},"2026-06-10","ACTUAL",{"date":46,"type":33},"2027-01-15",{"date":48,"type":33},"2027-09-15",{"name":5,"class":6}]